Graft-versus-host disease: pathophysiological and clinical aspects.
about
Pulmonary cytolytic thrombi: a newly recognized complication of stem cell transplantation.Cunninghamella infection post bone marrow transplant: case report and review of the literature.Combined simultaneous kidney/bone marrow transplantationPrevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506.Recent advances in the treatment of graft-versus-host disease.Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen.Allogeneic and autologous bone-marrow transplantation.Corneal transplantation--immunologically privileged status.Advances in the treatment of acute graft-versus-host disease.Balance of Th1 and Th17 effector and peripheral regulatory T cells.Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic functionFailure of trilineage blood cell reconstitution after initial neutrophil engraftment in patients undergoing allogeneic hematopoietic cell transplantation - frequency and outcomes.Nutrition support in bone marrow transplant recipients.One is better than two: TCR pairing and GVHD.Clinical significance of anti-endothelial cell antibody in allogeneic hematopoietic stem cell transplantation recipients with graft-versus-host disease.Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis iRandomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study.Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion.Bone marrow transplantation in beta-thalassemia major. The Israeli experience.Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation.Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease.Serum soluble tumor necrosis factor-related apoptosis-inducing ligand level after allogeneic hematopoietic cell transplantation.Differences in MHC-class I presented minor histocompatibility antigens extracted from normal and graft-versus-host disease (GVHD) mice.Pre-transplantation thymic function is associated with the risk of acute graft versus host disease and cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation.Increased nitric oxide (NO) production by antigen-presenting dendritic cells is responsible for low allogeneic mixed leucocyte reaction (MLR) in primary biliary cirrhosis (PBC).Graft-versus-Host disease-like syndrome in malignant thymoma.[Graft-versus-host disease: Review of 22 cases].
P2860
Q33837113-EF8037B5-7762-4B53-9B3C-336F19B4ABE2Q33940655-B75BE078-5C86-4353-BB6A-057AD7AD7959Q34232727-7FBF45EE-B4F2-4E22-A6F4-0FACAFD16F5CQ34286877-42694ED9-1446-47D3-B660-F5BFFAC7AFEDQ36148596-7495A020-2250-48C4-ACF5-DEF20F765E68Q36370863-5D518B60-411B-475A-9A12-9BAD0DF8CF26Q36403106-62B08E90-0C4D-4E61-8BBE-D89E702D8A90Q36415109-F2040F2B-14E3-49F3-95C1-4D0AA9AF8F22Q36974599-C392253A-E61D-4A4A-9F77-1A11DBA477A7Q37191057-43281FCE-63E8-420C-9DCE-9505AF6A2E02Q37450160-1CA6DDAC-356C-4B3D-B88F-BD52DE909AE2Q39946725-08AADB9D-6782-420B-AF64-A49143C9D34EQ40534164-5073CC0A-7AB3-48A9-A0BE-CCBA887E5D75Q40887528-A612F1E1-8056-4B0E-8778-E06C34D57C56Q43559416-BCB56017-A3EE-45BB-B7B7-90C551184B50Q44322030-DD5A637E-329C-43BF-84B7-B8D9F4F1525CQ44499723-0CC1BAF3-7A74-4D78-92B1-12B42CB5DC0AQ44571762-9F8201A5-BADE-4359-82A7-0669EAAB2C88Q44707075-48DEE0A5-D7BE-431F-9A91-A5B75F6004E3Q44853396-0730F32B-8066-4525-922E-1BBD390C15E1Q44956449-69C61F97-5074-4AF7-A768-E225A36153D3Q47407924-E16517AB-92D3-46A3-81D0-E64F27D23F61Q47771919-3A8BB161-361D-496E-ABD6-7A4AA3FFA456Q48017258-0FE10A2E-5C64-448D-BBEF-61F344106612Q48114774-0FF57746-FCE7-44CB-B430-4DA1E863F781Q51094364-65C4BB26-064B-4B6F-BB50-E064076C4777Q52540134-A55952AA-AFA6-40F6-BA0C-65EA45BD9DB1Q53877026-332DABF4-28E1-4B6E-B765-35383EDB6714
P2860
Graft-versus-host disease: pathophysiological and clinical aspects.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Graft-versus-host disease: pathophysiological and clinical aspects.
@en
type
label
Graft-versus-host disease: pathophysiological and clinical aspects.
@en
prefLabel
Graft-versus-host disease: pathophysiological and clinical aspects.
@en
P1476
Graft-versus-host disease: pathophysiological and clinical aspects.
@en
P356
10.1146/ANNUREV.ME.35.020184.000303
P577
1984-01-01T00:00:00Z